| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |